Q3FY17: Dr Reddy's Laboratories' net profit down 19% at Rs 470 crore
GV Prasad, Co-chairman of Dr Reddy's Laboratories said, "Our performance in Q3 has delivered a modest sequential revenue growth of 3% over the previous quarter. Our EBITDA has improved significantly from the last quarter to Rs 8.8 billion, on the back of enhanced emphasis on operational efficiencies and controlling of SG&A cost across all our business."
Dr Reddy reported consolidated net profit of Rs 470.1 crore in Q3, down by 8.83% from Rs 579.2 crore in the corresponding period of the previous year. Photo: Pixabay